ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

Cramer, Paige E., Cirrito, John R., Wesson, Daniel W., Lee, C. Y. Daniel, Karlo, J. Colleen, Zinn, Adriana E., Casali, Brad T., Restivo, Jessica L. +5 more·2012·Science

Cited by (1,000)

Items 801–900 of 1,000

  1. Early Treatment Critical: Bexarotene Reduces Amyloid-Beta Burden In Silico
    Joseph Rosenthal, Georges Belfort, David Isaacson · 2016 · PLoS ONE
  2. Preclinical PET Neuroimaging of [ 11 C]Bexarotene
    Benjamin H. Rotstein, Michael S. Placzek, Hema S. Krishnan, Aleksandra Pekošak, Thomas Lee Collier, Changning Wang, Steven H. Liang, Ethan S. Burstein, Jacob M. Hooker, Neil Vasdev · 2016 · Molecular Imaging
  3. Astrocytes in a dish: Using pluripotent stem cells to model neurodegenerative and neurodevelopmental disorders
    Lucy Crompton, Oscar Cordero Llana, Maeve A. Caldwell · 2017 · Brain Pathology
  4. Evaluating Novel RXR Agonists That Induce ApoE and Tyrosine Hydroxylase in Cultured Human Glioblastoma Cells
    Sanchita Mallick, Pamela A. Marshall, Carl E. Wagner, Michael C. Heck, Zhela L. Sabir, Marya S. Sabir, Christoper M. Dussik, Aleksandra Grozić, Ichiro Kaneko, Peter W. Jurutka · 2021 · ACS Chemical Neuroscience
  5. The effect of sodium channels on neurological/neuronal disorders: A systematic review
    Shokufeh Bagheri, Rasool Haddadi, Sahar Saki, Masoumeh Kourosh‐Arami, Alireza Komaki‬ · 2021 · International Journal of Developmental Neuroscience
  6. Targeting amyloid precursor protein shuttling and processing - long before amyloid beta formation
    Sage Arbor · 2017 · Neural Regeneration Research
  7. Enhancing of cerebral Abeta clearance by modulation of ABC transporter expression: a review of experimental approaches
    David A. Loeffler · 2024 · Frontiers in Aging Neuroscience
  8. Lipid metabolism and neurodegeneration: Mechanistic insights and therapeutic targets
    Yessenia Marroquin Salas, Kevin M. Kemper, Santhanam Shanmughapriya, Dianne Langford, Kalimuthusamy Natarajaseenivasan · 2026 · Ageing Research Reviews
  9. Amyloid β oligomers disrupt piriform cortical output via a serotonergic pathway
    Xiaojie Wang, Mengxi Hu, Xie Qian, Chi Geng, Chen Jin, Wei Ren, Jiangpeng Fan, Tengfei Ma, Bin Hu · 2022 · Neurobiology of Aging
  10. 9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer’s disease neuropathology and neuroinflammation in Alzheimer’s disease-like mouse models
    Rachel Twitto‐Greenberg, Sigal Liraz Zaltsman, Daniel M. Michaelson, Ori Liraz, Irit Lubitz, Dana Atrakchi, Chen Shemesh, Uri Ashery, Itzik Cooper, Ayelet Harari et al. · 2023 · Neurobiology of Aging
  11. Quantification of COX-2 Level in Alzheimer’s Disease Patients to Develop Potential Blood-Based Biomarker for Early Diagnosis and Therapeutic Target
    Sakshi Kumari, Priyajit Kaur, Abhinay Kumar Singh, Mohd Suhail Ashar, Rashmita Pradhan, Abhijit Rao, Partha Haldar, Avinash Chakrawarty, Prasun Chatterjee, Sharmistha Dey · 2024 · Journal of Alzheimer s Disease
  12. Defining a vitamin A5/X specific deficiency – vitamin A5/X as a critical dietary factor for mental health
    Diána Bánáti, Julian Hellmann‐Regen, Isabelle Mack, Hayley Anne Young, David Benton, Manfred L. Eggersdorfer, Sascha Rohn, Joanna Dulińska-Litewka, Wojciech Krężel, Ralph Rühl · 2024 · International Journal for Vitamin and Nutrition Research
  13. Allopregnanolone as a Therapeutic to Regenerate the Degenerated Brain
    Gerson D. Hernandez, Roberta Dı́az Brinton · 2019 · ISGE series
  14. Bexarotene treatment increases dendritic length in the nucleus accumbens without change in the locomotor activity and memory behaviors, in old mice
    Elibeth Monroy, Alfonso Díaz, Hiram Tendilla‐Beltrán, Fidel de la Cruz, Gonzalo Flores · 2019 · Journal of Chemical Neuroanatomy
  15. Type II nuclear receptors with potential role in Alzheimer disease
    Jonathan Muñoz-Cabrera, Sandoval-Hernández Adrián, Gonzalo Arboleda · 2021 · Molecular Aspects of Medicine
  16. Biological processes and key druggable targets involved in age-associated memory loss: A systematic review
    P. Ambili Unni, Girinath G. Pillai, S. Sajithalulu · 2021 · Life Sciences
  17. Ex Vivo Investigation of Bexarotene and Nicotinamide Function as a Protectıve Agent on Rat Synaptosomes Treated with Aβ(1-42)
    Ceyhan Hacıoğlu, Fatih Kar, Güngör Kanbak · 2021 · Neurochemical Research
  18. Synthesis and evolution of neuroprotective effects of oxymatrine derivatives as anti‐Alzheimer’s disease agents
    Peiliang Dong, Zhengqing Li, Cui‐li Teng, Xin Yin, Xian‐Kai Cao, Hua Han · 2021 · Chemical Biology & Drug Design
  19. The Janus-like Association between Proton Pump Inhibitors and Dementia
    Anna Papazoglou, Muhammad Imran Arshaad, Christina Henseler, Johanna Daubner, Karl Broich, Britta Haenisch, Marco Weiergräber · 2021 · Current Alzheimer Research
  20. High-Phytate Diets Increase Amyloid β Deposition and Apoptotic Neuronal Cell Death in a Rat Model
    Hyojung Kim, Yun-Shin Jung, YunJae Jung, Ok‐Hee Kim, Byung‐Chul Oh · 2021 · Nutrients
  21. Therapeutic Strategies for Neurodegenerative Diseases
    Jacques Fantini, Nouara Yahi · 2015 · Elsevier eBooks
  22. Drug development in dementia
    Emma Louise Cunningham, Anthony Peter Passmore · 2013 · Maturitas
  23. Chronic Cladribine Administration Increases Amyloid Beta Peptide Generation and Plaque Burden in Mice
    Crystal D. Hayes, Debleena Dey, Juan Pablo Palavicini, Hongjie Wang, Wataru Araki, Madepalli Krishnappa Lakshmana · 2012 · PLoS ONE
  24. Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review
    Aleksandra Marchwicka, Alan Cunningham, Ewa Marcinkowska, Geoffrey Brown · 2016 · Expert Opinion on Therapeutic Patents
  25. Loss of retinoid X receptor gamma subunit impairs group 1 mGluR mediated electrophysiological responses and group 1 mGluR dependent behaviors
    Chirag Upreti, Caitlin M. Woodruff, Xiaolei Zhang, Michael Yim, Zhenyu Zhou, Andrew Pagano, Dina S. Rehanian, Deqi Yin, Eric R. Kandel, Patric K. Stanton et al. · 2021 · Scientific Reports
  26. Red Blood Cell Omega-3 Fatty Acid Levels and Markers of Accelerated Brain Aging
    Steven Robert Brenner · 2012 · Neurology
  27. A Natural‐Product Switch for a Dynamic Protein Interface
    Marcel Scheepstra, Lidia Nieto, Anna K. H. Hirsch, Sascha Fuchs, S. Leysen, Chan Vinh Lam, Leslie in het Panhuis, Constant A. A. van Boeckel, Hans Wienk, Rolf Boelens et al. · 2014 · Angewandte Chemie
  28. Cancer drugs with high repositioning potential for Alzheimer’s disease
    Jad Majeed, Marwan Noel Sabbagh, Min H. Kang, J. Josh Lawrence, Kevin Pruitt, Sarah S. Bacus, Ellie Reyna, Maddy Brown, Boris Decourt · 2023 · Expert Opinion on Emerging Drugs
  29. Skin-brain axis in Alzheimer's disease - Pathologic, diagnostic, and therapeutic implications: A Hypothetical Review
    Hyeon soo Kim, Haram Jung, Yong‐Ho Park, Su‐Hak Heo, Sujin Kim, Minho Moon · 2024 · Aging and Disease
  30. Unraveling novel mechanisms of ATP-Binding cassette (ABC) transporter in insulin Resistance-induced amyloidogenesis
    AKHIL KUMAR SHARMA, Ashi Mannan, Thakur Gurjeet Singh · 2025 · Metabolic Brain Disease
  31. Overview of Alzheimer's and Parkinson's diseases and the role of protein aggregation in these neurodegenerative diseases
    Mariah J. Lelos · 2020 · Elsevier eBooks
  32. Sleep deprivation modulates APOE and LDL receptor-related protein 1 through thyroid hormone T4 and impairs Aβ clearance in hippocampus of rats
    Márcio Henrique Mello da Luz, Jessica Monteiro Volejnik Pino, Marcos Mônico‐Neto, Priscila Nicolicht, Hanna Karen Moreira Antunes, Marimelia Aparecida Porcionatto, Kil Sun Lee · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  33. Synthesis of a new fluorine-18-labeled bexarotene analogue for PET imaging of retinoid X receptor
    Min Wang, Toni Davis, Mingzhang Gao, Qi‐Huang Zheng · 2014 · Bioorganic & Medicinal Chemistry Letters
  34. Apolipoprotein E and Amyloid-β-Independent Mechanisms in Alzheimer’s Disease
    Takahisa Kanekiyo, Guojun Bu · 2016 · Elsevier eBooks
  35. Measuring Olfactory Processes in Mus musculus
    Heather Macintosh Schellinck · 2017 · Behavioural Processes
  36. Longitudinal Assessment of Working Memory Performance in the APPswe/PSEN1dE9 Mouse Model of Alzheimer’s Disease Using an Automated Figure-8-Maze
    Fran C. van Heusden, Sara Palacín i Bonsón, Oliver Stiedl, August Benjamin Smit, Ronald E. van Kesteren · 2021 · Frontiers in Behavioral Neuroscience
  37. Determination of Alteration in Micromeritic Properties of a Solid Dispersion: Brunauer-Emmett-Teller Based Adsorption and Other Structured Approaches
    Lovepreet Singh, Lakhvir Kaur, Gurjeet Singh, Ravi Kumar Dhawan, Manjeet Kaur, Navdeep Kaur, Prabhpreet Singh · 2022 · AAPS PharmSciTech
  38. Psychiatric disturbances regulate the innate immune system in CSF of conscious mice
    Emmanuel Shan Onaivi, Norman Schanz, Zhiyong Lin · 2014 · Translational Psychiatry
  39. Revitalizing Remyelination—the Answer Is Circulating
    Stephanie Redmond, Jonah R. Chan · 2012 · Science
  40. Unraveling the Function of PPARα in Neurodegenerative Disorders: A Potential Pathway to Novel Therapies
    Ourania-Natalia Galanou, Maria Konstandi · 2025 · Biomedicines
  41. Rexinoids Induce Differential Gene Expression in Human Glioblastoma Cells and Protein–Protein Interactions in a Yeast Two-Hybrid System
    Jennifer F. Hackney, Jennifer Broatch, Rita A. Dallal, Christian Brotherson, Sarah Livingston, Zhela L. Sabir, Sabeeha Mushtaq Reshi, Samantha R. Faltermeier Petras, Sanchita Mallick, Michael T. Applegate et al. · 2024 · ACS Chemical Neuroscience
  42. Seco-Prenylated Butylphloroglucinol Derivatives from Hypericum elodeoides and Their Anti-Alzheimer’s Disease Activities
    Wenjing Tian, Shoulun He, Sheng Zhong, Miaoyunhuan Wang, Lin Yingting, Jingyu Sun, Guanghui Wang, Xiaobin Li, Haifeng Chen · 2025 · Organic Letters
  43. Structure-based virtual screening for identification of potential non-steroidal LXR modulators against neurodegenerative conditions
    Sonam Deshwal, Anurag T. K. Baidya, Rajnish Kumar, Rajat Sandhir · 2022 · The Journal of Steroid Biochemistry and Molecular Biology
  44. Neurocognitive trajectory and proteomic signature of inherited risk for Alzheimer’s disease
    Manish D. Paranjpe, Mark D. Chaffin, Sohail Zahid, Scott C. Ritchie, Jerome I. Rotter, Stephen S. Rich, Robert Edgardo Gerszten, Xiuqing Guo, Susan R. Heckbert, Russ Tracy et al. · 2022 · PLoS Genetics
  45. Anti-inflammatory effects of 9-cis-retinoic acid on β-amyloid treated human microglial cells
    Sanjay Sanjay, Jae Young Kim · 2022 · European Journal of Inflammation
  46. Causal Mediation Analysis for Multivariate Longitudinal Data and Survival Outcomes
    Xiaoxiao Zhou, Xinyuan Song · 2023 · Structural Equation Modeling A Multidisciplinary Journal
  47. Vitamin B12 as an epidrug for regulating peripheral blood biomarkers in long COVID-associated visuoconstructive deficit
    Larissa Marcely Gomes Cassiano, Jonas Jardim de Paula, Daniela Valadão Rosa, Débora Marques de Miranda, Marco Aurélio Romano‐Silva, Roney S. Coimbra · 2025 · Scientific Reports
  48. The Diagnosis and Treatment of Alzheimer’s: Are We Being (Ir)responsible?
    Peter John Whitehouse · 2016 · Palgrave Macmillan UK eBooks
  49. Cholesterol and Fat Metabolism in Alzheimer’s Disease
    Changiz Taghibiglou, Siavash Khalaj · 2016 · Elsevier eBooks
  50. Gene regulation and genetics in neurochemistry, past to future
    Steven W. Barger · 2016 · Journal of Neurochemistry
  51. Development and validation of bexarote by bioanalytical methods using liquid chromatography-tandem mass spectroscopy (LC-MS/MS)
    K. Nagaraju, Y. A. Chowdary, Mandava Venkata Basaveswara Rao · 2021 · Future Journal of Pharmaceutical Sciences
  52. Aggregate Trends of Apolipoprotein E on Cognition in Transgenic Alzheimer’s Disease Mice
    Yassin Watson, Brenae Nelson, Jamie Hernandez Kluesner, Caroline Tanzy, Shreya Ramesh, Zoey Patel, Kaci Hernandez Kluesner, Anita Singh, Vibha Murthy, Cassie S. Mitchell · 2021 · Journal of Alzheimer s Disease
  53. Monocytic elastase-mediated apolipoprotein-E degradation: Potential involvement of microglial elastase-like proteases in apolipoprotein-E proteolysis in brains with Alzheimers disease
    Suenaga, Midori, Furuta, Akiko, Wakabayashi, Koichi, Saibara, Toshiji, Matsunaga, Yoichi · 2015 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  54. Neuroprotective Effects of Bexarotene and Icariin in a Diabetic Rat Model
    Dilek Ağırcan, Tuğba Melike Parlak, Öznur Tufan, Muhammed Demircioğlu, Burak Dik · 2024 · Cureus
  55. Retinoid-X-Receptor as a Mediator of Poststroke Recovery by Reversing Age-Associated Phenotypes of Microglia/Hematogenous Macrophages
    Shun‐Ming Ting, Xiurong Zhao, Guanghua Sun, Mercedes Ricote, Jaroslaw A Aronowski · 2025 · Journal of Neuroscience
  56. Euphorbia diterpenoids from Euphorbia peplus possessing anti-Alzheimer's activity via targeting PPARγ and upregulating the level of ABCA1
    Yanlan Yang, Shoulun He, Ying‐Ting Lin, Junjie Chen, Renjing Yang, Xueli Li, Jingyu Sun, Guanghui Wang, Wenjing Tian, Haifeng Chen · 2025 · Phytochemistry
  57. The LXR/RXR Approaches in Alzheimer’s Disease: Is the Blood-Bra in Barrier the Forgotten Partner?
    Pietra Candela Laurence Fenart · 2013 · Journal of Alzheimer’s Disease & Parkinsonism
  58. Suppression of amyloid-β fibril growth by drug-engineered polymorph transformation
    Sima Mafimoghaddam, Yuechuan Xu, Michael B. Sherman, Elena V. Orlova, Prashant Karki, Mehmet A. Orman, Peter G. Vekilov · 2022 · Journal of Biological Chemistry
  59. Lymphatic endothelial cell RXRα is critical for 9‐cis‐retinoic acid‐mediated lymphangiogenesis and prevention of secondary lymphedema
    Cynthia Sung, Jiao Wan, Sun Young Park, Michael N. Cooper, Antoun Bouz, Dahae Choi, Eunson Jung, Gene H. Kim, Young Kwon Hong, Alex K. Wong · 2022 · The FASEB Journal
  60. Nanoscale insights into the local structural rearrangements of amyloid-β induced by bexarotene
    Kamila Sofińska, Piotr Batys, Adrian Cernescu, Dhiman Ghosh, Katarzyna Skirlińska‐Nosek, Jakub Barbasz, Sara Seweryn, Natalia Wilkosz, Roland Riek, Marek Szymoński et al. · 2023 · Nanoscale
  61. Apolipoprotein E Plasma Concentrations Are Predictive of Recurrent Strokes: Insights From the SPARCL Trial
    Kévin Chemello, Alexis F. Guédon, Romuald Techer, Ali K. Jaafar, Sam Guilhen, Michael J. Swietek, Gilles C. Lambert, Antonio Gallo · 2025 · Journal of the American Heart Association
  62. Diarylamines Incorporating Hexahydrophenalene or Octahydrobenzoheptalene as Retinoid X Receptor (RXR)-Specific Agonists
    Yohei Amano, Masayuki Noguchi, Koichi Shudo · 2014 · Chemical and Pharmaceutical Bulletin
  63. Doubts about Targretin in AD
    Lev Z. Osherovich · 2013 · Science-Business eXchange
  64. Review Article APOE ε4: The most prevalent yet understudied risk factor for Alzheimer's disease
    Daniel M. Michaelson · 2014
  65. Bexarotene cannot reduce amyloid beta plaques through inhibition of production of amyloid beta peptides: in silico and in vitro study
    Pham Dinh Quoc Huy, Nguyen Quoc Thai, Zuzana Bednáriková, Huynh Quang Linh, Zuzana Gažová, Mai Suan Li · 2018 · Physical Chemistry Chemical Physics
  66. The Impact of Apolipoprotein E Allelic Variants on Alzheimer’s Disease
    Ezequiel Serrano, Pablo G. Sanz, Francisco José Barrantes · 2021 · Springer eBooks
  67. Hybrid Nanomaterials as Novel Therapeutic and Imaging Modalities
    Mayank Handa, Vanshul Saini, Shourya Tripathi, Awesh Kumar Yadav, Rahul Shukla · 2023 · Springer eBooks
  68. Towards Small Molecules as Therapies for Alzheimer’s Disease and Other Neurodegenerative Disorders
    Omar Aziz, Roland W. Bürli, David F. Fischer, Julie A. Frearson, Michael D. Wall · 2014 · Elsevier eBooks
  69. Retinoids and PPAR agonists: Promising partners in neurodegenerative diseases?
    Javier Riancho · 2016 · Free Radical Biology and Medicine
  70. Influence of electroacupuncture therapy of tonifying the kidney and regulating governor vessel on Aβ related degradation enzymes in the hippocampus of a rat model of Alzheimer's disease induced by Aβ1-42
    Yanjun Du, Shuang-Hong Tang, Jia-huan Xiao, Yun Wang, Qing Tian, Guojie Sun · 2018 · 世界针灸杂志:英文版
  71. Fluorescence properties of retinoid X receptor antagonist NEt-SB
    Shoya Yamada, Yuta Takamura, Michiko Fujihara, Mayu Kawasaki, Sohei Ito, Shogo Nakano, Hiroki Kakuta · 2020 · Bioorganic & Medicinal Chemistry Letters
  72. Emerging Therapeutic Strategies in Alzheimer's Disease
    Tomohiro Chiba · 2013 · InTech eBooks
  73. Lipids and Lipoproteins in Alzheimer’s Disease
    Sophie K. Stukas, Iva Kulić, Shahab Zareyan, Cheryl Lea Wellington · 2015 · InTech eBooks
  74. Neuroprotection by dietary restriction and the PPAR transcription complex
    Charles V. Mobbs, Cesar L. Moreno, Esther Kim, Nydia Ekasumara, Bridget Kelly Marcellino · 2012 · Translational Neuroscience
  75. A Knowledge-based Integrative Modeling Approach for In-Silico Identification of Mechanistic Targets in Neurodegeneration with Focus on Alzheimer's Disease
    Erfan Younesi · 2014
  76. What's New on Alzheimer's Disease? Insights From AD Mouse Models
    Christophe C. Rey, Vanessa Cattaud, Claire Rampon, Laure Verret · 2019 · Elsevier eBooks
  77. Substrate interaction inhibits γ-secretase production of amyloid-β peptides
    Jing Zhao, Yuanyuan Xiao, Xinyue Liu, Soohyun Kim, Xianzhong Wu, Marilia Barros, Ran Zhuang, Xuben Hou, Yingkai Zhang, Nikolaos K. R K Robakis et al. · 2020 · Chemical Communications
  78. Characterization of selective and potent inhibitors of the human retinoic acid hydroxylases CYP26A1 and CYP26B1
    Brian Buttrick · 2013 · ResearchWorks at the University of Washington (University of Washington)
  79. Moderate ethanol exposure reduces astrocyte-induced neuroinflammatorysignaling and cognitive decline in presymptomatic APP/PS1 mice
    S. Kang, Jeyeon Lee, Sun Choi, Jarred J. Nesbitt, Paul H. Min, E. Trushina, Doo-Sup Choi · 2023 · Research Square
  80. RXR-Mediated Remodeling of Transcriptional and Chromatin Landscapes in APP Mouse Brain: Insights from Integrated Single-Cell RNA and ATAC Profiling
    Lu Yi, Xuebao Wang, Carolina Saibro Girardi, Nicholas Francis Fitz, Radosveta P. Koldamova, Iliya M. Lefterov · 2025 · Cells
  81. Protective Effects of Cirsium japonicum var. maackii Flower on Amyloid Beta25–35-Treated C6 Glial Cells
    Qi Pang, Sanghyun Lee, Eun Ju Cho, Ji-Hyun Kim · 2023 · Life
  82. Dicer1 promotes Aβ clearance via blocking B2 RNA-mediated repression of apolipoprotein E
    Yan Wang, Meiling Lian, Xiaoyu Xiu, Zhiwen Zhang, Liping Song, Shengzhou Wu · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  83. Identification of Proteins Responsible for the Neuroprotective Effect of the Secretome Derived from Blood Cells of Remote Ischaemic Conditioned Rats
    Petra Bonová, Jana Končeková, Miroslava Némethová, Klaudia Petrová, Martin Bona, Miroslav Gottlieb · 2022 · Biomolecules
  84. Analysing and Evaluating Complementarity of Multi-Modal Data Fusion in AD Diagnosis
    Zhaodong Chen, Fengtao Nan, Yun Yang, Jiayu Wang, Po Yang · 2022 · International Conference on Mobility, Sensing and Networking (MSN)
  85. Drug repurposing for neurodegenerative diseases
    Halak Shukla, Diana John, Shuvomoy Banerjee, Anand Krishna Tiwari · 2024 · Progress in molecular biology and translational science
  86. Perspectives on the Role of APOE4 as a Therapeutic Target for Alzheimer’s Disease
    Kavita Patel, Siwangi Srivastava, Shikha Kushwah, Ashutosh Mani · 2021 · Journal of Alzheimer s Disease Reports
  87. Apolipoprotein E and Mimetics as Targets and Therapeutics for Alzheimer’s Disease
    Michael Peter Vitek, Fengqiao Li, Carol A. Colton · 2015 · Springer eBooks
  88. Pathogenesis, modulation, and therapy of Alzheimer’s disease: A perspective on roles of liver-X receptors
    Jasminka Štefulj, Ute Panzenboeck, Patrick R. Hof, Goran Šimić · 2013 · Translational Neuroscience
  89. The ABCA7 transporter, brain lipids and Alzheimer’s disease
    Stephanie J. Soscia, Michael L. Fitzgerald · 2013 · Clinical Lipidology
  90. Ability to Recall Specific Detail and General Detail (Gist) in Young Old, Middle Old, and Older Adults
    Victoria E. Alexander, Mark Bahr, Richard E. Hicks · 2015 · Psychology
  91. Vitamin A and Cognitive Impairment
    Patrick Sauvant, Catherine Féart, Julie Sauvant, Véronique Pallet · 2014 · Elsevier eBooks
  92. Neuroregeneration: Disease Modeling and Therapeutic Strategies for Alzheimer’s and Parkinson’s Diseases
    Angel J. Santiago-Lopez, Candice M. Hovell, Hyunjung Lee, YongTae Kim · 2015 · Biosystems & biorobotics
  93. The expression of insulin-like growth factor-1 in senior patients with diabetes and dementia
    Yanling Zhou, Shuqing Liu, Bin Yuan, Ning Lü · 2016 · Experimental and Therapeutic Medicine
  94. Mediation of insulin growth factor-1 in Alzheimer's disease and the mechanism of PRNP genetic expression and the PI3K/Akt signaling pathway
    Guohong Jiang, Changming Wang, Jun Zhang, Haijun Liu · 2017 · Experimental and Therapeutic Medicine
  95. Recent Advances in Neurodegeneration
    Antonella Borreca · 2019 · IntechOpen eBooks
  96. Targeting Liver X Receptors in Cancer Drug Discovery
    Asitha Premaratne, Abhinav Bagchi, Shinjini Basu, Jan-Ακε Gustafsson, Chin‐Yo Lin · 2024 · Receptors
  97. Doubly Robust Triple Cross-Fit Estimation for Causal Inference with Imaging Data
    Da Ke, Xiaoxiao Zhou, Qinglong Yang, Xinyuan Song · 2024 · Statistics in Biosciences
  98. Long-term intermittent fasting induces region- and sex-specific changes in astrocyte morphology and expression and anxiety-like behaviors in CD-1 mice
    Minerva Ortiz‐Valladares, Diana Amezcua-Cárdenas, Ricardo Pedraza‐Medina, Christian Peregrino-Ramírez, Esmeralda Rojas-Cobián · 2025 · Behavioural Brain Research
  99. Activation of RXRα mitigates maternal separation-induced hippocampal neurodevelopmental impairment in mice by inhibiting oxidative stress and restoring mitochondrial homeostasis
    Shijie Zhang, Daowei Tang, Yuanyuan Liu, Ziye Zang, Senyue Yang, Haidong Wei, Xing Lü, Jianhong Li · 2025 · Free Radical Biology and Medicine
  100. Amyloid-β clearance: an astrocytic perspective
    Jiayi Li, Zhongyue Lv, X P Chen, Fan Fu, Kaixia Yang, Guogang Lai, Hao Wu, Guomin Xie · 2026 · Frontiers in Neuroscience